echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > J Gastroenterology: Analysis of the efficacy of nasal gastric tube sorority or long tube therapy for non-narrow acute small intestine obstruction.

    J Gastroenterology: Analysis of the efficacy of nasal gastric tube sorority or long tube therapy for non-narrow acute small intestine obstruction.

    • Last Update: 2020-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Background gastrointestinal decompression is usually used in the treatment of non-narrow acute small intestine obstruction (NSASBO).
    Although in previous studies, long tube (LT) placement of a combination nasal gastric tube (NGT-G) injection of pan-contrast glutamine is better than the use of NGT alone, there has been no study to compare LT and NGT-G, so the study aims to compare the differences in efficacy between the two.
    method in this multicenter randomized controlled trial, researchers will be randomly assigned to RECEIVE LT or NGT-G treatment in patients with non-narrow intestinal obstruction (NSASBO) between July 2016 and November 2018.
    the main endpoint is the non-surgical efficacy of NGT-G compared to LT.
    results In this trial, a total of 223 patients were analyzed (LT group, n s 111; NGT-G group, n s 112). The non-surgical rate of the
    LT group was 87.4%, the non-surgical rate in the NGT-G group was 91.1%, and the difference between NGT-G and LT was 3.7% (95.3% CI-5.55 to 12.91;
    on the other hand, the non-surgical rate (76.8%) of the use of pure NGT-G alone represents a significantly lower non-surgical rate than the non-crossNGT-G non-surgical rate of non-follow-up LT (P - 0.039).
    NGT-G had significantly less neutral surgery time than LT (1 min VS 25 minutes; P.lt;0.001), and there was no significant difference in mortality or hospital stay between the two groups.
    concluded that NGT-G is an effective alternative to LT and can be used as a first-line treatment drug for NSASBO.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.